Vaccination Status and Symptom Severity in Covid-19 Patients
DOI:
https://doi.org/10.31965/infokes.Vol23.Iss1.1351Keywords:
COVID-19, Severity of Symptom, Vaccination StatusAbstract
We are still attempting to reduce COVID-19 morbidity and mortality through several means, including immunization. In early December 2021, Indonesia had 49.19% coverage of the second COVID-19 vaccination. Researching and collecting data on the association between vaccine completion and symptom severity is critical to persuade individuals to vaccinate. This study aims to examine the relationship between COVID-19 vaccination status and the degree of symptom severity in COVID-19 patients. This cross-sectional study used secondary data from the medical records of COVID-19 patients at the PDHI Yogyakarta Islamic Hospital from June to October 2021. The "PeduliLindungi" application was used to acquire vaccination status information. We used the chi-square test and multiple logistic regression for bivariate and multivariate analyses. The study enrolled 112 participants who met the criteria. The severity of COVID-19 symptoms was related to vaccination status and hypertension. Patients who were unvaccinated or had only partially vaccinated were 62.383 times more likely to develop severe and critical severity (aOR 62.383; 95% CI 12.129-320.861). Patients with hypertension were 3.643 times more likely than those without hypertension to experience severe or critical symptoms (aOR=3.643; 95% CI 1.025-12.952). Male gender, elderly age, chronic lung illness, and diabetes mellitus slightly increased the likelihood of severe symptoms but were not statistically significant. Complete immunization is strongly advised to reduce the risk of severe or critical symptoms.
Downloads
References
Agrawal, U., Bedston, S., McCowan, C., Oke, J., Patterson, L., Robertson, C., ... & Sheikh, A. (2022). Severe COVID-19 outcomes after full vaccination of primary schedule and initial boosters: pooled analysis of national prospective cohort studies of 30 million individuals in England, Northern Ireland, Scotland, and Wales. The Lancet, 400(10360), 1305-1320. https://doi.org/10.1016/S0140-6736(22)01656-7.
Arce, J. S. S., Warren, S. S., Meriggi, N. F., Scacco, A., McMurry, N., Voors, M., ... & Omer, S. B. (2021). COVID-19 vaccine acceptance and hesitancy in low-and middle-income countries. Nature medicine, 27(8), 1385-1394. https://doi.org/10.1038/s41591-021-01454-y
Baj, J., Karakuła-Juchnowicz, H., Teresiński, G., Buszewicz, G., Ciesielka, M., Sitarz, R., ... & Maciejewski, R. (2020). COVID-19: specific and non-specific clinical manifestations and symptoms: the current state of knowledge. Journal of clinical medicine, 9(6), 1753. https://doi.org/10.3390/jcm9061753
Bhattacharya, A., Ranjan, P., Ghosh, T., Agarwal, H., Seth, S., Maher, G. T., ... & Wig, N. (2021). Evaluation of the dose-effect association between the number of doses and duration since the last dose of COVID-19 vaccine, and its efficacy in preventing the disease and reducing disease severity: A single centre, cross-sectional analytical study from India. Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 15(5), 102238. https://doi.org/10.1016/j.dsx.2021.102238
CNN Indonesia. (2021, July). BOR di Yogyakarta Nyaris 100 Persen, 3 RS Lapangan Disiapkan [Internet]. CNN Indonesia. Retrieved from: https://www.cnnindonesia.com/nasional/20210714161638-20-667701/bor-di-yogyakarta-nyaris-100-persen-3-rs-lapangan-disiapkan
Damarjati, T. (2021). BOR Nyaris 100 Persen, Pemda DIY Berencana Buka 3 RS Lapangan. IDN Times Jogja. Retrieved from: https://jogja.idntimes.com/news/jogja/tunggul-damarjati/pemda-diy-berencana-buka-3-rs-lapangan?page=all
Freund, O., Tau, L., Weiss, T. E., Zornitzki, L., Rydman, S., Jacob, G., & Bornstein, G. (2022). Associations of vaccine status with characteristics and outcomes of hospitalized severe COVID-19 patients in the booster era. PLoS ONE, 17(5), e0268050. https://doi.org/10.1371/journal.pone.0268050
He, Y., He, Y., Hu, Q., Yang, S., Li, J., Liu, Y., & Hu, J. (2022). Association between smoking and COVID-19 severity: A Multicentre retrospective observational study. Medicine, 101(29), e29438. http://dx.doi.org/10.1097/MD.0000000000029438
Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., Zhang, L., Fan, G., Xu, J., Gu, X., Cheng, Z., Yu, T., Xia, J., Wei, Y., Wu, W., Xie, X., Yin, W., Li, H., Liu, M., … Cao, B. (2020). Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet, 395(20), 497–506. https://doi.org/10.1016/ S0140-6736(20)30183-5
Indonesian Ministry of Health. (2021). Vaksinasi COVID-19 Nasional. Indonesian Ministry of Health. Retrieved from: https://vaksin.kemkes.go.id/#/vaccines
Karya, K. W. S., Suwidnya, I. M., & Wijaya, B. S. (2021). Hubungan penyakit komorbiditas terhadap derajat klinis COVID-19. Intisari Sains Medis, 12(2), 708–717. https://doi.org/10.15562/ism.v12i2.1143
Keni, R., Alexander, A., Nayak, P. G., Mudgal, J., & Nandakumar, K. (2020). COVID-19: emergence, spread, possible treatments, and global burden. Frontiers in public health, 8, 216. https://doi.org/10.3389/fpubh.2020.00216
Lauring, A. S., Tenforde, M. W., Chappell, J. D., Gaglani, M., Ginde, A. A., McNeal, T., ... & Self, W. H. (2022). Clinical severity of, and effectiveness of mRNA vaccines against, covid-19 from omicron, delta, and alpha SARS-CoV-2 variants in the United States: prospective observational study. 376, e069761. https://doi.org/10.1136/bmj-2021-069761
Liu, Y., Mao, B., Liang, S., Yang, J.-W., Lu, H.-W., Chai, Y.-H., Wang, L., Zhang, L., Li, Q.-H., Zhao, L., He, Y., Gu, X.-L., Ji, X.-B., Li, L., Jie, Z.-J., Li, Q., Li, X.-Y., Lu, H.-Z., Zhang, W.-H., … Xu, J.-F. (2020). Association between age and clinical characteristics and outcomes of COVID-19. Eur Respir J, 55, 2001112. https://doi.org/10.1183/13993003.01112-2020
Ng, O. T., Marimuthu, K., Lim, N., Lim, Z. Q., Thevasagayam, N. M., Koh, V., ... & Tan, C. C. (2022). Analysis of COVID-19 incidence and severity among adults vaccinated with 2-dose mRNA COVID-19 or inactivated SARS-CoV-2 vaccines with and without boosters in Singapore. JAMA network open, 5(8), e2228900-e2228900. https://doi.org/10.1001/jamanetworkopen.2022.28900
Nugraheni, A. P., & Sulistyawati, S. (2023). COVID-19 vaccine acceptance in Notoprajan, Yogyakarta, Indonesia: a lesson learned from the pandemic. Int J Public Health Sci, 12(3), 924–931. https://doi.org/10.11591/ijphs.v12i3.22976
Özdemir, Ö. (2020). Coronavirus Disease 2019 (COVID-19): Diagnosis and Management. Erciyes Med J, 42(3), 242–247. https://doi.org/10.14744/etd.2020.99836
Sallam, M. (2021). COVID-19 Vaccine Hesitancy Worldwide: A Concise Systematic Review of Vaccine Acceptance Rates. Vaccines, 9, 160. https://doi.org/10.3390/vaccines9020160
SATGAS COVID-19. (2021). Indonesia fights back the covid-19 second wave. SATGAS COVID-19.
Speiser, D. E., & Bachmann, M. F. (2020). COVID-19: Mechanisms of vaccination and immunity. Vaccines, 8(3), 404. https://doi.org/10.3390/vaccines8030404
Sridhar, S., Begom, S., Bermingham, A., Hoschler, K., Adamson, W., Carman, W., Bean, T., Barclay, W., Deeks, J. J., & Lalvani, A. (2013). Cellular immune correlates of protection against symptomatic pandemic influenza. Nat Med, 19(10), 1305–1312. https://doi.org/10.1038/nm.3350
Stalter, R. M., Atluri, V., Xia, F., Thomas, K. K., Lan, K. F., Greninger, A. L., & Patel, R. C. (2022). Elucidating Pathways Mediating the Relationship Between Male Sex and COVID-19 Severity. Clin Epidemiol, 14, 115–125. https://doi.org/10.2147/CLEP.S335494
Tizazu, A. M., Mengist, H. M., & Demeke, G. (2022). Aging and immunosenescence as risk factors of severe COVID-19. Immun Ageing, 19(1), 53. https://doi.org/10.1186/s12979-022-00309-5
Vahidy, F. S., Pan, A. P., Ahnstedt, H., Munshi, Y., Choi, A., Tiruneh, Y., Nasir, K., Kash, B. A., Andrieni, J. D., & Mccullough, L. D. (2021). Sex differences in susceptibility , severity , and outcomes of coronavirus disease 2019: Cross- sectional analysis from a diverse US metropolitan area. PLoS ONE, 16(1), e0245556. https://doi.org/10.1371/journal.pone.0245556
Wang, D., Hu, B., Hu, C., Zhu, F., Liu, X., Zhang, J., Wang, B., Xiang, H., Cheng, Z., Xiong, Y., Zhao, Y., Li, Y., Wang, X., & Peng, Z. (2020). Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus–Infected Pneumonia in Wuhan, China. JAMA, 323(11), 1061–1069. https://doi.org/10.1001/jama.2020.1585
Wang, X., Zhou, Y., Liu, L., Ma, J., Wu, H., Zhao, L., Chen, W., Li, S. C., Ran, Q., & Li, Z. (2020). Coronavirus disease 2019 (COVID-19): diagnosis and prognosis. Blood Genom, 4(2), 96–107. https://doi.org/10.46701/BG.2020022020120
World Health Organization. (2020). Statement on the second meeting of the International Health Regulations (2005) Emergency Committee regarding the outbreak of novel coronavirus (2019-nCoV). Geneva, World Health Organization.Retrieved from: https://www.who.int/news/item/30-01-2020-statement-on-the-second-meeting-of-the-international-health-regulations-(2005)-emergency-committee-regarding-the-outbreak-of-novel-coronavirus-(2019-ncov)
Winduajie, Y. (2021, July). UPDATE Covid-19 DI Yogyakarta 22 Juli 2021:Tambah 1.978 Kasus Baru, 88 Pasien Dilaporkan Meninggal. TribunJogja.Com. Retrieved from: https://jogja.tribunnews.com/2021/07/22/udpate-covid-19-di-yogyakarta-22-juli-2021tambah-1978-kasus-baru-88-pasien-dilaporkan-meninggal
World Health Organization. (2020). Therapeutics and COVID-19. World Health Organization.
Wu, F., Zhou, Y., Wang, Z., Xie, M., Shi, Z., Tang, Z., Li, X., Li, X., Lei, C., Li, Y., Ni, Z., Hu, Y., Liu, X., Yin, W., Cheng, L., Ye, F., Peng, J., Huang, L., Tian, J., … Ran, P. (2020). Clinical characteristics of COVID-19 infection in chronic obstructive pulmonary disease: A multicenter, retrospective, observational study. J Thorac Dis, 12(5), 1811–1823. https://doi.org/10.21037/jtd-20-1914
Zu, Z. Y., Jiang, M. Di, Xu, P. P., Chen, W., Ni, Q. Q., Lu, G. M., & Zhang, L. J. (2020). Coronavirus Disease 2019 (COVID-19): A Perspective from China. Radiology, 296(2), E15–E25. https://doi.org/10.1148/radiol.2020200490
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 JURNAL INFO KESEHATAN
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Copyright notice
Ownership of copyright
The copyright in this website and the material on this website (including without limitation the text, computer code, artwork, photographs, images, music, audio material, video material and audio-visual material on this website) is owned by JURNAL INFO KESEHATAN and its licensors.
Copyright license
JURNAL INFO KESEHATAN grants to you a worldwide non-exclusive royalty-free revocable license to:
- view this website and the material on this website on a computer or mobile device via a web browser;
- copy and store this website and the material on this website in your web browser cache memory; and
- print pages from this website for your use.
- All articles published by JURNAL INFO KESEHATAN are licensed under the Creative Commons Attribution 4.0 International License. This permits anyone to copy, redistribute, remix, transmit and adapt the work provided the original work and source is appropriately cited.
JURNAL INFO KESEHATAN does not grant you any other rights in relation to this website or the material on this website. In other words, all other rights are reserved.
For the avoidance of doubt, you must not adapt, edit, change, transform, publish, republish, distribute, redistribute, broadcast, rebroadcast or show or play in public this website or the material on this website (in any form or media) without appropriately and conspicuously citing the original work and source or JURNAL INFO KESEHATAN prior written permission.
Permissions
You may request permission to use the copyright materials on this website by writing to [email protected].
Enforcement of copyright
JURNAL INFO KESEHATAN takes the protection of its copyright very seriously.
If JURNAL INFO KESEHATAN discovers that you have used its copyright materials in contravention of the license above, JURNAL INFO KESEHATAN may bring legal proceedings against you seeking monetary damages and an injunction to stop you using those materials. You could also be ordered to pay legal costs.
If you become aware of any use of JURNAL INFO KESEHATAN copyright materials that contravenes or may contravene the license above, please report this by email to [email protected]
Infringing material
If you become aware of any material on the website that you believe infringes your or any other person's copyright, please report this by email to [email protected].
